IXICO plc announced the appointment of Kate Rogers as a Non-Executive Director and Chair of the Audit Committee with effect from 21 January 2022. John Bradshaw, who has served as a non-executive director and Chair of the Audit Committee since October 2013, has informed the Board of his intention to retire owing to his length of service on the IXICO Board with effect from 30 April 2022. His responsibilities as IXICO's Chair of the Audit Committee will be assumed by Kate Rogers with immediate effect.

Kate is currently leading the transformation of Glaxo SmithKline's global finance organisation having previously worked as CFO for Laboratoire Glaxo SmithKline SaS (GSK France) as well as other senior finance roles within GSK.